These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 26629255
1. Mesenchymal stem cells preconditioned with trimetazidine promote neovascularization of hearts under hypoxia/reoxygenation injury. Hu X, Yang J, Wang Y, Zhang Y, Ii M, Shen Z, Hui J. Int J Clin Exp Med; 2015; 8(9):16991-7005. PubMed ID: 26629255 [Abstract] [Full Text] [Related]
2. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. Wisel S, Khan M, Kuppusamy ML, Mohan IK, Chacko SM, Rivera BK, Sun BC, Hideg K, Kuppusamy P. J Pharmacol Exp Ther; 2009 May; 329(2):543-50. PubMed ID: 19218529 [Abstract] [Full Text] [Related]
8. Trimetazidine Preconditioning Potentiates the Effect of Mesenchymal Stem Cells Secretome on the Preservation of Rat Pancreatic Islet Survival and Function In Vitro. Ahmadi F, Lotfi AS, Navaei-Nigjeh M, Kadivar M. Appl Biochem Biotechnol; 2023 Aug; 195(8):4796-4817. PubMed ID: 37184724 [Abstract] [Full Text] [Related]
10. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA, Wei L. J Thorac Cardiovasc Surg; 2008 Apr; 135(4):799-808. PubMed ID: 18374759 [Abstract] [Full Text] [Related]
11. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Herrmann JL, Wang Y, Abarbanell AM, Weil BR, Tan J, Meldrum DR. Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917 [Abstract] [Full Text] [Related]
12. Trimetazidine Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury by Promoting AMP-activated Protein Kinase-dependent Autophagic Flux. Zhong Y, Zhong P, He S, Zhang Y, Tang L, Ling Y, Fu S, Tang Y, Yang P, Luo T, Chen B, Chen A, Wang X. J Cardiovasc Pharmacol; 2017 Jun; 69(6):389-397. PubMed ID: 28581448 [Abstract] [Full Text] [Related]
13. The effect of Trimetazidine and Diazoxide on immunomodulatory activity of human embryonic stem cell-derived mesenchymal stem cell secretome. Jahandideh S, Maghsood F, Ghahhari NM, Lotfinia M, Mohammadi M, Johari B, Kadivar M. Tissue Cell; 2017 Oct; 49(5):597-602. PubMed ID: 28843336 [Abstract] [Full Text] [Related]
14. Can ischemic preconditioning protect against hypoxia-induced damage? Studies of contractile function in isolated perfused rat hearts. Cave AC, Horowitz GL, Apstein CS. J Mol Cell Cardiol; 1994 Nov; 26(11):1471-86. PubMed ID: 7897671 [Abstract] [Full Text] [Related]
15. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats. Xie X, Sun A, Zhu W, Huang Z, Hu X, Jia J, Zou Y, Ge J. Tohoku J Exp Med; 2012 Jan; 226(1):29-36. PubMed ID: 22186034 [Abstract] [Full Text] [Related]
16. Enhancement of angiogenic effects by hypoxia-preconditioned human umbilical cord-derived mesenchymal stem cells in a mouse model of hindlimb ischemia. Han KH, Kim AK, Kim MH, Kim DH, Go HN, Kim DI. Cell Biol Int; 2016 Jan; 40(1):27-35. PubMed ID: 26222206 [Abstract] [Full Text] [Related]
17. Repair of Critical-Sized Mandible Defects in Aged Rat Using Hypoxia Preconditioned BMSCs with Up-regulation of Hif-1α. Zhang J, Feng Z, Wei J, Yu Y, Luo J, Zhou J, Li Y, Zheng X, Tang W, Liu L, Long J, Li X, Jing W. Int J Biol Sci; 2018 Jan; 14(4):449-460. PubMed ID: 29725266 [Abstract] [Full Text] [Related]